An Idiographic Examination of Treatment Mechanisms in Emotion Regulation Therapy (NCT05590741) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
An Idiographic Examination of Treatment Mechanisms in Emotion Regulation Therapy
United States24 participantsStarted 2022-11-16
Plain-language summary
This study is an open trial designed to examine individual changes that occur before, during, and after 12 sessions of Emotion Regulation Therapy (ERT) delivered via telehealth for individuals in New York State who are experiencing elevated worry, rumination, or self-criticism.
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Between the ages of 18 and 65
* Fluent in English (and therefore able to provide consent)
* Currently living in New York State
* Access to at least one device with internet and video-conferencing capabilities
* High self-reported worry, rumination, and/or self-criticism
* Meet Diagnostic and Statistical Manual of Mental Disorders - Fifth Edition (DSM-5) criteria for at least one, current psychological disorder
Exclusion Criteria:
* Active suicidal ideation or intent
* Substance dependence disorder, schizophrenia, bipolar-I disorder, or a primary DSM-5 diagnosis of borderline or narcissistic personality disorder
* Currently in therapy or receiving any type of psychosocial treatment
* Individuals taking psychotropic mediation that has not been stabilized for a period of at least 3 months
* Current students at Teachers College, Columbia University
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Weekly Assessment of Change in Attentional Control
Timeframe: Weekly from Baseline (2 weeks) through Treatment (12 weeks) and Follow-Up (4 weeks)
2
Weekly Assessment of Change in Decentering
Timeframe: Weekly from Baseline (2 weeks) through Treatment (12 weeks) and Follow-Up (4 weeks)
3
Weekly Assessment of Change in Reappraisal
Timeframe: Weekly from Baseline (2 weeks) through Treatment (12 weeks) and Follow-Up (4 weeks)
4
Weekly Assessment of Change in Valued Living/Action
Timeframe: Weekly from Baseline (2 weeks) through Treatment (12 weeks) and Follow-Up (4 weeks)
5
Weekly Assessment of Change in Clarity of Approach-Avoidance Motivation
Timeframe: Weekly from Baseline (2 weeks) through Treatment (12 weeks) and Follow-Up (4 weeks)